AstraZeneca BioVentureHub

This years summer update has just been released - full with info about a new innovation platform, new companies joining our innovation hub, collaborations and memberships and last but not least some international recognition.

So stay tuned. And if you haven't signed up to our newsletter - please do. Then you will get the news direct to your mailbox.
 

BridgeHouse is a new innovation platform, bringing together industry leaders - AstraZeneca, Scania and RISE, to collaborate with innovative small and medium-sized enterprises, focusing on sustainability technology. 
BridgeHouse builds on BioVentureHubs proven innovation model, where emerging companies can accelerate and scale alongside a global pharma partner. BridgeHouse spans R&D through BioVentureHub, and a new team has been established at our Operations site in Södertälje.

We are welcoming new companies into our innovation hub at AstraZeneca R&D site in Gothenburg. 
Together, we will accelerate innovation by connecting you with our scientists, world class infrastructure, and a collaborative culture, while contributing to de-risk your growth journey. 
Now we are looking for emerging companies, developing SustainTechsolutions related to Green Chemistry & Biocatalysis.

Nordic Life Science Days 2025, at Svenska Määsan in Gothenburg is over. Great to be able to welcome all delegates, exhibitors, investors, innovators, country delegations and companies, talents and public and industry organisations to the city of Gothenburg. Together with our fellow colleagues and Business RegionGothenburg, who has been instrumental in holding things together, we hope to welcome you back in the near future.

A big thank you to all who visited our booth, listened and shared knowledge, ideas, possibilities and experiences on stages, in headphones, in partnering meetings and at the venues, morning, day, evening, and to the NLS-Days and Sweden Bio team, for a superb organisation of this event, with top level of friendliness, experiences and support.
 

“When two global life science leaders join forces in an open innovation environment, truly exceptional conditions for breakthrough discovery and progress are created.

Welcoming Thermo Fisher Scientific into BioVentureHub at AstraZeneca’s strategic R&D centre in Gothenburg, marks a significant step and unlocks dynamic opportunities for open scientific co-creation between AstraZeneca and Thermo Fisher Scientific. Magnus Björsne, CEO, AstraZeneca BioVentureHub said.

AstraZeneca’s BioVentureHub is more than an innovation hub—it’s a sustainability accelerator for life science and sustainability tech innovators. With a sharper focus on attracting sustainability tech companies and research, the BioVentureHub offers a unique environment where companies can co-locate, scale and innovate while integrating sustainable business practices. 

Sweden’s position as a global innovation leader is deeply rooted in its unique culture of collaboration and resourcefulness. As a nation of just 10 million people —smaller than the city of Paris—we’ve long embraced the need to share resources, knowledge, and expertise to remain competitive.

Since BioVentureHub established 2014, we have created a lot of value, together with our member companies, collaborative AstraZeneca scientists and ecosystem partners. There are many things that sets us apart from our colleagues in the innovation industry. One thing specifically is the unique dare to share culture based on experimental, explorative and sometimes trial and error approach and experience. It takes years of curiosity in order to create the future together. Learn more about BioVentureHub.


                                                      

In an effort to provide you with a window into the BioVentureHub community, we seek to outline the inherent value of participating in this thriving ecosystem.
By exploring these narratives, you will gain an understanding of how the BioVentureHub fosters the growth of emerging life science companies, drives pioneering advancements, and nurtures an environment of collaborative innovation.

We are highlighting four companies, with unique contributions and various approaches; Lucero, Nyctea Technologies, NanoSIMS and Waters.

A testament to the success of the BioVentureHub is evident in the growth stories of three of our alumni companies based at GoCo Health Innovation City.

OnDosis, Promimic, and I-Tech leveraged the resources and expertise available at the BioVentureHub to accelerate their development, secure investments and reach significant business milestones.

Read more about their impactful growth journeys.

We offer world class facilities and opportunities. We care about the scientific outcomes, supporting AstraZeneca´s ambitions, just as we care about You and your ambitions to collaborate and grow.
Being a scientific and business minded entreprenaur is tough. If you make it into the community, we offer the best possible support. But it is always up to you to fit in good company. Up for a challenge?